335 related articles for article (PubMed ID: 20525678)
1. Transdermal and oral hormone replacement therapy and the risk of stroke: a nested case-control study.
Renoux C; Dell'aniello S; Garbe E; Suissa S
BMJ; 2010 Jun; 340():c2519. PubMed ID: 20525678
[TBL] [Abstract][Full Text] [Related]
2. Hormone replacement therapy use and the risk of stroke.
Renoux C; Dell'aniello S; Garbe E; Suissa S
Maturitas; 2008 Dec; 61(4):305-9. PubMed ID: 18996656
[TBL] [Abstract][Full Text] [Related]
3. Hormone replacement therapy use and variations in the risk of breast cancer.
Opatrny L; Dell'Aniello S; Assouline S; Suissa S
BJOG; 2008 Jan; 115(2):169-75; discussion 175. PubMed ID: 18081598
[TBL] [Abstract][Full Text] [Related]
4. Transdermal hormone therapy and the risk of stroke and venous thrombosis.
Speroff L
Climacteric; 2010 Oct; 13(5):429-32. PubMed ID: 20670199
[TBL] [Abstract][Full Text] [Related]
5. Hormone therapy and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration and progestogens: the ESTHER study.
Canonico M; Oger E; Plu-Bureau G; Conard J; Meyer G; Lévesque H; Trillot N; Barrellier MT; Wahl D; Emmerich J; Scarabin PY;
Circulation; 2007 Feb; 115(7):840-5. PubMed ID: 17309934
[TBL] [Abstract][Full Text] [Related]
6. Comparison of continuation of postmenopausal hormone replacement therapy: transdermal versus oral estrogen.
Ettinger B; Pressman A; Bradley C
Menopause; 1998; 5(3):152-6. PubMed ID: 9774760
[TBL] [Abstract][Full Text] [Related]
7. Persistence with oral and transdermal hormone replacement therapy and hospitalisation for cardiovascular outcomes.
Corrao G; Zambon A; Nicotra F; Fornari C; La Vecchia C; Mezzanzanica M; Nappi RE; Merlino L; Cesana G
Maturitas; 2007 Jul; 57(3):315-24. PubMed ID: 17485182
[TBL] [Abstract][Full Text] [Related]
8. Post-menopausal hormone replacement therapy (cont'd): risk-benefit balance in the hot seat.
Prescrire Int; 2004 Jun; 13(71):106-9. PubMed ID: 15233153
[TBL] [Abstract][Full Text] [Related]
9. Prothrombotic mutations, hormone therapy, and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration.
Straczek C; Oger E; Yon de Jonage-Canonico MB; Plu-Bureau G; Conard J; Meyer G; Alhenc-Gelas M; Lévesque H; Trillot N; Barrellier MT; Wahl D; Emmerich J; Scarabin PY;
Circulation; 2005 Nov; 112(22):3495-500. PubMed ID: 16301339
[TBL] [Abstract][Full Text] [Related]
10. Hormone replacement therapy containing progestins and given continuously increases breast carcinoma risk in Sweden.
Olsson HL; Ingvar C; Bladström A
Cancer; 2003 Mar; 97(6):1387-92. PubMed ID: 12627501
[TBL] [Abstract][Full Text] [Related]
11. Postmenopausal Hormone Therapy and Risk of Stroke: Impact of the Route of Estrogen Administration and Type of Progestogen.
Canonico M; Carcaillon L; Plu-Bureau G; Oger E; Singh-Manoux A; Tubert-Bitter P; Elbaz A; Scarabin PY
Stroke; 2016 Jul; 47(7):1734-41. PubMed ID: 27256671
[TBL] [Abstract][Full Text] [Related]
12. Increased thrombin generation among postmenopausal women using hormone therapy: importance of the route of estrogen administration and progestogens.
Scarabin PY; Hemker HC; Clément C; Soisson V; Alhenc-Gelas M
Menopause; 2011 Aug; 18(8):873-9. PubMed ID: 21487317
[TBL] [Abstract][Full Text] [Related]
13. Continuation of postmenopausal hormone replacement therapy in a large health maintenance organization: transdermal matrix patch versus oral estrogen therapy.
Ettinger B; Pressman A
Am J Manag Care; 1999 Jun; 5(6):779-85. PubMed ID: 10538456
[TBL] [Abstract][Full Text] [Related]
14. Tamoxifen, hormone receptors and hormone replacement therapy in women previously treated for breast cancer: a cohort study.
Dew JE; Wren BG; Eden JA
Climacteric; 2002 Jun; 5(2):151-5. PubMed ID: 12051110
[TBL] [Abstract][Full Text] [Related]
15. Comparison of effects of continuous combined transdermal with oral estrogen and oral progestogen replacement therapies on serum lipoproteins and compliance.
Erenus M; Karakoç B; Gürler A
Climacteric; 2001 Sep; 4(3):228-34. PubMed ID: 11588947
[TBL] [Abstract][Full Text] [Related]
16. The influence of the route of oestrogen administration on serum levels of cortisol-binding globulin and total cortisol.
Qureshi AC; Bahri A; Breen LA; Barnes SC; Powrie JK; Thomas SM; Carroll PV
Clin Endocrinol (Oxf); 2007 May; 66(5):632-5. PubMed ID: 17492949
[TBL] [Abstract][Full Text] [Related]
17. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.
Stanosz S; Zochowska E; Safranow K; Sieja K; Stanosz M
Metabolism; 2009 Jan; 58(1):1-7. PubMed ID: 19059524
[TBL] [Abstract][Full Text] [Related]
18. Postmenopausal hormone therapy and risk of idiopathic venous thromboembolism: results from the E3N cohort study.
Canonico M; Fournier A; Carcaillon L; Olié V; Plu-Bureau G; Oger E; Mesrine S; Boutron-Ruault MC; Clavel-Chapelon F; Scarabin PY
Arterioscler Thromb Vasc Biol; 2010 Feb; 30(2):340-5. PubMed ID: 19834106
[TBL] [Abstract][Full Text] [Related]
19. Hormone therapy and recurrence of venous thromboembolism among postmenopausal women.
Olié V; Plu-Bureau G; Conard J; Horellou MH; Canonico M; Scarabin PY
Menopause; 2011 May; 18(5):488-93. PubMed ID: 21178641
[TBL] [Abstract][Full Text] [Related]
20. Epidemiologic aspects of exogenous progestagens in relation to their role in pathogenesis of human breast cancer.
van Leeuwen FE
Acta Endocrinol (Copenh); 1991; 125 Suppl 1():13-26. PubMed ID: 1801500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]